Home
Biogen BIIB spent $1.1M on lobbying in Q3 2023 · Health Issues, Medicare and 4 more issues
Trade details
- Type
- Lobbying report
- Amount
- $1,090,000
- Quarter
- Q3 2023
- Stock
- Biogen BIIB
- Client
- Biogen
- Reported
- 23/10/19
Up 31.3% from last quarter
What else happened in Biogen around then
Filed or reported within 30 days of the trade day · 23/08/31~23/10/30Biogen's other lobbying reports
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$1.1M
$1.1M
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$60K
$60K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 04/20
for Q1